Naive T cells in the periphery mainly secrete interleukin (IL) 2 upon activation. After stimulation in the presence of appropriate costimulators, both CD4 + and CD8 + T cells differentiate into effector cells secreting distinct T helper (Th) l-and Th2-1ike cytokine patterns. Subsequent to differentiation, both CD4 + (Thl and Th2) and CD8 + (TC1 and TC2) cells are stable and cannot be induced to differentiate into the opposite pattern or revert to the naive cytokine secretion pattern. We now show that IL-4 caused committed TC1 bulk populations or clones to lose the ability to synthesize IL-2. The cells retained the ability to secrete interferon (IFN) % granulocyte/macrophage colony-stimulating factor, and tumor necrosis factor, did not synthesize any Th2 cytokines, and did not alter cell surface marker expression. IL-4 rapidly inhibited IL-2--synthesizing ability in the absence or presence of antigen-presenting cells, thus demonstrating that IL-4 acted direcdy on TC1 cells. The defect in IL-2 synthesis could not be reversed by subsequent stimulation with potent antigen-presenting cells in the presence of IL-2 and anti-IL-4, or with anti-CD3 plus anti-CD28 antibodies. Both IL-2 + and IL-2-TC1 cells were strongly cytotoxic toward allogeneic but not syngeneic targets. However, IL-2-TC1 cells were unable to proliferate unless exogenous IL-2 was provided. TC1 cells that lose IL-2 synthesis but retain IFN-'y synthesis and cytotoxicity may be similar to the "anergic" cells induced by stimulation of CD4 + or CD8 § cells in the absence of costimulators. These results suggest that during a mixed type 1/type 2 response in vivo, IL-4 may induce the IL-2 § TC1 -~ IL-2-TC1 conversion, and thus curtail the expansion of the TC1 response without impairing short-term effector function.
F
unctionally different subsets of CD4 + and CD8 + cells have important regulatory and effector roles in immune responses. Based on the cytokine synthesis patterns of longterm clones, CD4 + T cells were classified into Thl (IL-2, IFN-~/and TNF- [3) and Th2 (IL-4, IL-5, IL-6, IL-10, and IL-13) (1-3). Many of the functions ofT cells are mediated by cytokines that are secreted upon their stimulation. Thl cells, through their production of IFN-~ and TNF- [3, induce delayed-type hypersensitivity and microbicidal activity in macrophages (cellular immunity), whereas Th2 cells secrete cytokines that help B cells become antibody-producing cells (humoral immunity) and enhance allergy (3) . Distinct cytokine-secreting subsets of CD8 + T cells have also been identified (4) (5) (6) (7) . Cytokine patterns of CD8 + subsets are similar to their CD4 + counterparts: TC1 cells secrete IL-2 and IFN-% and TC2 cells secrete IL-4, IL-5, IL-6, and IL-10. The existence of subsets of both CD4 + and CD8 + T ceils in vivo has been demonstrated in various infections (8) (9) (10) (11) (12) (13) .
Cytokines are the major factors that determine the differentiation of precursor T cells. IL-12, TGF-[3, and IFN-~/ induce the differentiation of naive CD4 + T cells into Thl but not Th2 cells (14) (15) (16) (17) , whereas IL-4 is essential for differentiation into Th2 cells and inhibits development of Thl cells (18, 19) . IFN-',/ and IL-4 also induce the differentiation of naive CD8 + T cells into TC1 and TC2 phenotypes, respectively (4) (5) (6) , and IL-12 enhances the cytotoxicity and IFN-~/production of CD8 + cells (20) . Cytokine-directed differentiation may be due to a combination of inhibitory and enhancing effects on the two arms of the differentiation pathway.
Cytokines secreted by Thl and Th2 cells also cross-regulate the proliferation or cytokine secretion of committed cells of the opposite subset (3) . IL-10 secreted by Th2 cells inhibits cytokine secretion by Thl cells (21, 22) . Similarly, IFN-~/ secreted by Thl cells inhibits the proliferation of Th2 but not Thl cells (23, 24) . Less has been known about the influence ofcytokines on the proliferation and cytokine secretion of committed CD8 + effector cells.
Subsequent to differentiation, effector T cells maintain a relatively stable cytokine secretion pattern, as they rarely, if ever, change into the opposite phenotype or revert to their precursor state. However, some alterations have been described. Th0 cells (secreting Thl and Th2 cytokines) become more Thl-or Th2-1ike in response to different cytokines (25, 26) . Stimulation of Th0 ceils with anti-CD3 in the absence ofcostimulators induced a shift to a more Th2-like phenotype (25) . In the absence of appropriate costimulators, for example, stimulation with antigen on fixed APC, both CD4 + Thl and CD8 + TC1 cells lose the ability to synthesize IL-2 and proliferate (27) (28) (29) . This "anergic" state was reversed when Thl cells were subsequently stimulated with allogeneic non-T cells (30) , IL-2, or IL-4 (31, 32), although reversal was not observed in another study (33) .
We now show that, in addition to the well-established effects of IL-4 on naive T cells, IL-4 inhibits the ability of differentiated CD8 + TC1 cells to synthesize IL-2. This was not reversed by IL-2 during or after IL-4 treatment. Loss of the ability to synthesize IL-2 did not impair TC1 functional capability, as both the IL-2-secreting (IL-2 +) and the IL-2-nonsecreting (IL-2-) CD8 + TC1 cells were highly cytolytic and secreted normal amounts of other TC1 cytokines (IFN-y, GM-CSF, and TNF). However, the subsequent proliferation oflL-2-TC1 cells became dependent on exogenous IL-2, suggesting that this may be another example of cross-inhibition of the type 1 and type 2 cytokine patterns.
Materials and Methods
Mice. Female C57BL/6 mice, 4-6-wk old, were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice were maintained in the Health Sciences Laboratory Animal Services (Edmonton, Alberta, Canada) in accordance with the the guidelines of the Canadian Council on Animal Care.
Cell Lines. The mouse hybrid B cell line M12.4.1 (34) expressing H-2 a was obtained from Dr. L. Glimcher. J774A.1 (mouse macrophage cell line expressing H-2d), P815, EL4, and WEHI-164-13 cell lines were obtained from American Type Culture Collection (Rockville, MD).
Cytokines, Antibodies, and Reagents. Mouse recombinant IL-2 was expressed in Escherichia coli (35) and used as a partially purified preparation at 2.5 ng/ml. Recombinant mouse IL-4 and IL-12 were expressed in COS cells and used as a dilution of COS transfection supernatants (36) . Hamster anti-mouse CD28 antibody clone 37.51 (37) was obtained from Dr. James P. Allison. Anti-IL-4 and anti-CD28 antibodies were purified on a protein G column from the supernatants of llBll (38) and 37. 51 Ceil Cultures. C57BL/6 CD8 + T cells were enriched by removal of B cells, CD4 + T cells, and macrophages on rat T columns (Biotex, Edmonton, Alberta, Canada). Splenocytes (150 • 10 6) were incubated with a rat anti-mouse CD4 antibody (clone YTS 191.1) and loaded onto glass bead columns coated with sheep anti-rat Ig (cross-reactive with mouse Ig). Cells that passed through the column were 80-90% CD8 + by FACScan ~~ analysis. In some experiments, CD8 + T cells were further purified by sorting on a cell sorter (EPICS Elite; Coulter Corp., Hialeah, FL) after staining the cells with rat anti-mouse Ly2-FITC (clone YTS 169.4). C57BL/6 CD8 § T cells (H-2 b, 103/well) were stimulated with 104 cells/well of irradiated (10,000 rad) allogeneic APC lines M12.4.1 (H-2 a, B cell lymphoma [34] ) and J774 (H-2 d, macrophage) in 96-well tissue culture plates in 200 ILl of RPMI plus 8% FBS in the presence of various cytokines. IL-2 was added at 2.5 ng/ml, and, where appropriate, anti-IL-4 (11Bll) at 25 [xg/ ml and IL-4 at 10 ng/ml were added unless otherwise mentioned. Media were changed every third day after splitting cultures as necessary.
For purification of CD4 § T cells, C57BL/6 splenocytes were incubated with a rat anti-mouse CD8 antibody (clone YTS 169.4) and processed as mentioned above for CD8 + T cell purification.
Cytokine secretion was determined after Con A stimulation (5 p~g/ml) ofeffector cells (106/ml) in 200 p~l of RPMI 1640 plus 8% FBS. Arithmetic means and SD of triplicate cultures were calculated.
Generation of Long-Term T Cell Clones. C57BL/6 CD8 + T cells were cloned by limiting dilution in the presence of cytokine combinations favoring differentiation into the TC1 (IL-2 + ILl2 + anti-lL-4) phenotype as described above. Limiting dilution cloning was carried out by stimulating the C57BL/6 CD8 + T cells (1,000 cells/well to 0.5 cell/well) with irradiated M12. CytokineAssays. Cytokines produced in the supernatants were measured by ELISA (39). The following antibodies were used: R4-6A2 (ATCC HB170) and XMG1.2-biotin (2) for IFN-~; BVD4-1D11 and BVD6-24G2-biotin (PharMingen) for IL-4; TP, FK5 (40) and TP, FK4-biotin (PharMingen) for IL-5; JES6-1A12 and JES6-5H4-biotin (PharMingen) for IL-2; 8F8 and 43D11-biotin (41) for IL-3; SXC2 and SXCl-biotin (42) for IL-10; 35E10 and 22E9-biotin for GM-CSF; and MP5-20F3 and MP5-32C11-biotin (PharMingen) for IL-6. TNF was assayed on WEHI-164.13 cells as described (43), except that the assay was carried out in the presence of saturating (5 ng/ml) amounts of IFN-~/.
Thymidine Incorporation. IL-2-or IL-2 + TC1 cells were generated by stimulating effector TC1 cells on day 6 with allogeneic J774A.1 cells in the presence or absence of IL-4 for another 6 d. On day 12, the proliferative capability of allospecific IL-2 + and IL-2-CD8 + TC1 cells was assessed by analyzing the incorporation of labeled thymidine every day for 4 d. TC1 cells (1.1 • 104 cells/ml) were stimulated with irradiated (10,000 rad) J774A.1 cells (5 • 104/ml) in 96-well flat-bottomed tissue culture plates in 200 I.tl RPMI 1640 plus 8% FBS in the presence or absence of various growth factors. Radiolabeled thymidine was added (1 ~Ci/ well) at the same time or after every 24 h. Cells were then harvested 24 h after the thymidine pulse, and radioactive incorporation was determined by liquid scintillation counting.
Cytotoxicity Assays. 6 vious findings (4), and IL-4 treatment did not alter these levels. Both IL-2 + and IL-2-TC1 cells expressed similar levels of CD8o~, CD8~, CD28, and CD44 and remained NKI.1- (Fig. 2) . Thus, IL-4-treated TC1 cells selectively lost the ability to subsequently secrete IL-2, without any other detectable alterations. This occurred even in the presence of exogenous IL-2.
Results

IL-4 Inhibits the Subsequent Ability of CD8 + TC1 Cells to Secrete IL-2 without Abrogating IFN-% GM-CSF, and TNF Synthesis or Altering Expression of Cell
IL-4 Induced the Loss of lL-2-synthesizing Ability during Stimulation of TC1 Cells by Either B Cell or Macrophage APC Lines.
To determine whether the loss of IL-2--synthesizing ability occurred under different stimulation conditions, we established allospecific TC1 cells by primary allostimulation with M12.4.1 (a B cell line) or J774A1 (a macrophage cell line) in the presence oflL-2, IL-12, and anti-IL-4 antibodies. When these established TC1 cells were restimulated with the same APC, IL-4 induced both TC1 populations to lose the subsequent ability to synthesize IL-2 (Fig.  3) . Synthesis of other cytokines (IFN-y and IL-4) was not aftbcted. Cytokine secretion Cytokine secretion Figure 7 . IL-4 does not abrogate IL-2 synthesis during short-term Con A activation ofcornmitted CD8 + TC1 cells. Allospecific IL-2 + and IL-2-TC1 cells were generated as mentioned in Fig. 1 . On day 12, cells were thoroughly washed and stimulated with Con A for 24 h in the presence or absence of IL-4. Cytokines were measured in the 24-h supematants.
IL-4-induced Loss of lL-2 Synthesis in
Cytokine secretion
the final Con A stimulation of IL-2 § TC1 cells, IL-2 synthesis was partially inhibited but not abrogated (Fig. 7) .
IL-4-induced Loss of lL-2 Synthesis by TC1 Cells Is Irreversible.
To determine whether the IL-4-induced loss of the ability of TC1 cells to secrete IL-2 was a transient phenomenon, IL-2 § or IL-2-TC1 cells were generated by stimulating effector TC1 cells on day 6 with allogeneic M12. (Fig. 8) , whereas the cells grown in the presence of IL-4 from days 6 to 18 lost their capacity to secrete IL-2 while retaining their IFN-y-producing capacity. IL-2 secretion was not restored if the IL-4-treated TC1 cells were stimulated with alloantigen in the presence of IL-2 plus anti-IL-4 from days 12 to 18. After induction of the IL-2-phenotype, we also attempted to restore IL-2 synthesis by stimulation with platebound anti-CD3 and anti-CD28 antibodies. Fig. 9 shows that anti-IL-4-pretreated TC1 cells produced substantial amounts of IL-2, and, in this experiment, IL-4-pretreated ceils produced a small amount of IL-2 at 24 but not 48 h. Anti-CD28 costimulation caused a fourfold enhancement of IL-2 secretion by both cell populations at 24 h. However, the lL-4-pretreated TCl ceils still produced 16-fold less IL-2 than controls. At 48 h, the control cultures maintaiued similar levels of IL-2, whereas no IL-2 was detectable in IL-4-pretreated cultures even with CD28 costimulation. Thus, in these experiments as well as others (results not shown), we have been unable to reverse the IL-4-induced defect in IL-2-producing capacity of TC1 cells.
CD8 + TC1 Cells Are More Susceptible than CD4 + Till Cells to IL-4-induced Loss of lL-2 Synthesis.
As long-term CD4 + clones can sometimes selectively lose the ability to synthesize IL-2 (Mosmann, T., unpublished observations), we tested whether IL-4 could also contribute to this effect. were harvested to analyze their cytolytic ability and cytokine production. Fig. 11 a confirms that cells grown in the presence of IL-4 do not synthesize IL-2, whereas the cells grown in anti-IL-4 or IL-12 plus anti-IL-4 remained IL-2+IFN-~/+. TC1 cells grown in all three growth conditions were cytolytic toward allogeneic (P815) but not syngeneic (EL4) targets (Fig. 11 b) . The cytotoxicity of the IL-2-cells was equal to that of the IL-2 + cells grown in IL-12, suggesting that IL-2 synthesis does not affect cytotoxicity.
Loss of lL-2 Synthesis Impairs Autonomous ProloCeration of TC1 Cells. We tested whether the lack of IL-2-synthesizing ability would render TC1 cells incapable of antigendependent proliferation. IL-2 + and IL-2-TC1 cells (Fig.  12 a) sis was then assessed by analyzing the incorporation of labeled thymidine every day for up to 4 d. Fig. 12 b demonstrates that in the absence of any exogenous cytokines, IL-2-and IL-2 + TC1 cells proliferated to a similar degree for the first day after antigen stimulation, whereas at later times proliferation continued in the IL-2 + population but declined rapidly in the IL-2-cells. Addition of exogenous growth factors slightly enhanced proliferation of IL-2 + TC1 cells at day 4, presumably because the cells had used up the IL-2 synthesized during the initial stimulation. On the other hand, exogenous IL-2 strongly enhanced the proliferation of the IL-2-TC1 cells, and, at 1.5 ng/ml, almost completely restored proliferation to the levels of IL-2 + cells. IL-4 also enhanced proliferation of IL-2-cells but did not fully restore proliferation even at 15 ng/ml. The combination oflL-2 (0.5 ng/ml) and [L-4 (15 ng/ml) fully restored proliferation of the [L-2-cells. Thus, antigenstimulated IL-2-TC1 cells remained responsive to T cell growth factors but were dependent on the provision of these cytokines from other sources.
Sad and Mosmann
Discussion
Antigen stimulation of naive CD4 + and CD8 + T cells in the presence oflL-12 and/or IFN-~/induces differentiation into the committed Thl and TC1 phenotypes, both secreting IL-2 and IFN-% However, long-term Thl clones often lose the ability to synthesize IL-2 while retaining IFN-~/synthesis (2). Among short-term CD8 + clones, some do not synthesize IL-2 even when first tested (4, 44) , suggesting that CD8 + T cells may more rapidly lose the ability to synthesize IL-2. We now show that IL-4 rapidly induced committed TC1 cells to lose their subsequent ability to synthesize IL-2 but not IFN-% GM-CSF, or TNF. Synthesis of IL-2 by Thl clones was also reduced by IL-4, although this required higher IL-4 concentrations, and complete loss was not observed. These results raise the possibility that endogenous IL-4 production by APC might account for the eventual loss of IL-2 synthesis by long-term clones.
The Finally, IL-4 may prevent the expression of a component of the signaling pathways, particularly in the B7-CD28/ CTLA4 pathway, which provides an essential costimulatory signal required for T cell stimulation, especially for IL-2 production (46). Expression of CD28 itself is similar on IL-2-and IL-2 + TC1 cells, but CTLA4 expression or a subsequent step in the signaling pathway may be altered.
During stimulation of naive T cells, IL-4 inhibits the generation of cells secreting the Thl/TC1 pattern of cytokines and induces the appearance of cells that secrete the Th2/TC2 pattern (4, 6, 18, 19) . IL-4 also inhibits the synthesis of IL-2 by naive CD4 + T cells in short-term culture (47). These effects are distinct from our current observation, as IL-4 induces naive cells to switch to the TC2 phenotype, whereas TC1 cells only lose the ability to secrete IL-2 but do not show other changes. In both cases, however, IL-4 induces differentiation rather than short-term modulation, as neither the naive CD8 + --+ TC2 nor the IL-2 + TC1 --+ IL-2-TC1 transitions are reversible. The effects of IL-4 on naive and committed cells may be brought about by different mechanisms, as IL-4-induced differentiation of naive CD8 + T cells into TC2 cells involves loss of IL-2 production accompanied by permanent alteration of the synthesis of several other cytokines, whereas the IL-2 + TC1 ---> IL-2-TC1 transition appears to be very selective, involving only the IL-2 gene.
When CD4 + Thl cells are stimulated in the presence of fixed APC or anti-CD3 antibodies, they selectively lose the ability to synthesize IL-2 and proliferate, while retaining cytotoxicity, secretion of other cytokines, and responsiveness to IL-2 (27, 28) . This state has been referred to as "anergy," although anergy previously meant a lack of effector function rather than a selective loss of autonomous proliferation. Most experiments on the induction of anergy have focused on CD4 + cells, but a similar state can be induced by stimulation of CD8 + cells with fixed APC (29) . These conditions allow TC1K engagement in the absence of the crucial second (costimulatory) signal mediated by APC. Although anergic CD4 + cells are unable to synthesize IL-2 and proliferate autonomously, they remain fully antigen re- The requirements for costimulation and the induction of anergy may be different for CD4 + and CD8 + T cells. CD4 + cells are stimulated by MHC class II + cells, which are often APC with strong costimulatory functions such as dendritic cells, B cells, and macrophages. In contrast, CD8 + cells can potentially recognize antigen on almost any nucleated cell, and so will often be stimulated with antigen/MHC in the absence of costimulation. Also, CD8 + effector T cells kill targets rapidly, so that there is little opportunity for the target cell to up-regulate expression of costimulators as occurs during CD4-APC interaction. Thus, CD8 + cells may require less costimulation than CD4 + cells, consistent with a report that fibroblasts can stimulate an efficient CD8 + response (48), although IL-2 synthesis was not measured. However, some requirement for costimulation is indicated by the ability of fixed APC to induce anergy in CD8 + ceils (29) . Another difference between CD4 + and CD8 + ceils may relate to sensitivity to IL-4. Human CD4 + cells can be anergized by APC lacking costimulators, and this is prevented by IL-4 (32). In contrast, our studies on mouse CD8 + cells demonstrate that they are "anergized" by IL-4.
Both the IL-2 + and IL-2-TC1 cells were highly cytotoxic when cultured in IL-12 and IL-4, respectively. Therefore, IL-2 secretion by a T cell during the effectortarget interaction does not appear to affect cytotoxicity. Similarly, cytotoxicity was retained by both CD4 + and CD8 + anergic T cells lacking IL-2-synthesizing ability induced by fixed APC (29, 49) . In contrast to their ability to kill target cells and synthesize other cytokines, TCl ceils that lacked IL-2-synthesizing ability were unable to proliferate when stimulated in the absence of exogenous growth factors. Proliferation was restored by the addition of IL-2, and to a lesser extent by IL-4. Thus, CD8 + TC1 cells lacking IL-2~ynthesizing ability appear to retain short-term ellector function (cytotoxicity) while losing their ability to proliferate autonomously.
Thus, the loss oflL-2 production by TC1 cells may have more effect on clonal expansion than on effector functions. If TC1 responses coexist with Th2 or TC2 responses in vivo, TC1 cells might lose their ability to secrete IL-2 because of local IL-4 secretion. This may impair clonal ex-pansion of the TC1 cells, as they would now be dependent on T cell growth factors produced by other cells, such as IL-2 and IL-4 produced by other T cells or IL-15 produced by nonlymphoid cells such as muscle cells, fibroblasts, or monocytes (50) . Because of these other sources of T cell growth factors in vivo, anergic T cells may show damping of responses in vivo in contrast to the abrogation of responses seen in tissue culture systems that lack many of the cell types that contribute to in vivo responses.
The induction of the TC1 IL-2-phenotype by IL-4 is consistent with other mechanisms whereby type 1 and type 2 responses cross-regulate each other. IL-10 and IL-4 produced by Th2 or TC2 cells inhibit IFN-~/synthesis and differentiation of Thl and TC1 cells (4, 18, 21, 22, 51) . Conversely, IFN-~/secreted by Thl and TC1 cells inhibits the proliferation of Th2 cells (23, 24) . Our results now suggest that Th2 and TC2 cells, via production of IL-4, may limit the extent of a TC1 response by preventing autonomous expansion in the absence of growth factors from other cells, but maintaining short-term effector functions.
